Bank Central Asia Tbk vs Cipta Sarana Medika Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,275 (market cap 774.97T, 14.22M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 9.51M 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 4823.4× Cipta Sarana Medika Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (14.22M versus 9.51M). Which is the better fit depends on your goals.
| BBCA | DKHH | |
|---|---|---|
Market Cap | 774.97T | 160.67B |
Volume | 14.22M | 9.51M |
Lot | 142.15K | 95.07K |
Turnover | 89.54B | 608.7M |
Average Price | 6,299.1 | 64.03 |
Value | 89.54B | 608.7M |
Indicative Equilibrium Price | 6,350 | 63 |
Indicative Equilibrium Volume | 2.2M | 4.8K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →